Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Oct 30 - Nov 4
Moderate Responders (3 to 6 weeks): Chronic injuries and more severe damage often require this longer timeframe to show significant improvement
leukemia and lymphomas, cancers invading the bone marrow
Separate-Vial Reconstitution Spec BAC water added BPC-157 (10 mg vial) 2.0 mL TB-500 (10 mg vial) 2.0 mL Spec Final concentration BPC-157 (10 mg vial) 5.0 mg/mL TB-500 (10 mg vial) 5.0 mg/mL Spec 10 units (0.10 mL) delivers BPC-157 (10 mg vial) 500 mcg TB-500 (10 mg vial) 500 mcg Spec 20 units (0.20 mL) delivers BPC-157 (10 mg vial) 1.0 mg TB-500 (10 mg vial) 1.0 mg Spec Doses per vial (typical) BPC-157 (10 mg vial) ~2040 days TB-500 (10 mg vial) ~45 loading doses This separate-vial row keeps the same 10 mg-per-compound assumption as the 20 mg pre-blend, but the compounds are reconstituted and drawn independently
While first explored as a treatment for shielding the stomach lining, it has subsequently earned awareness due to its restoration abilities in diverse tissues such as tendons
ACC1 is strictly cytosolic and is enriched in liver, adipose tissue, and lactating mammary tissue
